Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-09-06-Speech-3-247"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2000-09-06"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20000906.11.3-247"2
lpv:hasSubsequent	lp_eu:2000-09-06-Speech-3-2482
lpv:speaker	lp:Ilka Schröder2
lpv:spokenAs	substitute; ECON (1999-07-22--2001-09-27)3 member; G/EFA (1999-07-20--2001-09-27)3 substitute; Temporary committee on the Echelon interception system (2000-07-06--2001-09-05)3 member; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)3 member; Delegation for relations with the Palestinian Legislative Council (1999-09-28--2002-01-14)3 unknown; parteilos (2000-09-01--2004-07-19)3
lpv:translated text	"Commissioner, I am pleased to hear that certain measures are to be taken. Nevertheless, I call into question the fact that when the Commission encounters problems with the partners participating in particular projects, it attributes at least half of these problems to the partners themselves. I have information to the effect that even small project partners are in full possession of the facts about the contracts and know exactly what they have to submit. I have had a case described to me where the same paperwork was submitted on three separate occasions, but the Commission still maintained that it had never received this paperwork. I therefore wish to put in another request for the application procedure to be attended by extremely clear guidelines laid down in advance. I have encountered problems of this kind before, not just in the drugs sphere, but with many other partners that work with the Commission and seek co-financing. It is not only in the drugs sphere where the application procedure takes such a long time and is so complex, and I believe the problem does not lie wholly with incompetent, small project partners, but can also be put down to the fact that the requirements set by the Commission are not clearly formulated. The question remains as to whether we really want to cut back on the small organisations within the European Union, when it is important to support drugs projects – including those in the regions – using a whole range of approaches, specifically in this area, but also in general. I believe it would not be in our interests to only give large organisations a chance to move things forward in this sphere, rather our aim must continue to be that of promoting a variety of organisational structures. That would be a wholly misguided attempt at a solution to my mind."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph